Search research articles
Contact Us
Filters
Showing results (81-90 of 87) with videos related to
Page
of 9
Sort By:
You have reached the last page of results.
This site can display upto 87 results.
Plos One
|
March 21, 2015
Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients
Kelly R Reveles, Timothy R Juday, Matthew J Labreche, et al.
BMC Microbiology
|
January 15, 2021
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling
Meghan I Short, Robert Hudson, Benjamin D Besasie, et al.
The Oncologist
|
June 19, 2023
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration
Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, et al.
Open Forum Infectious Diseases
|
January 30, 2020
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With <i>Clostridioides difficile</i> Infection
Travis J Carlson, Bradley T Endres, Julie Le Pham, et al.
Drug and Alcohol Dependence
|
June 12, 2022
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
Lucas G Hill, Lindsey J Loera, Sorina B Torrez, et al.
Antibiotics (Basel, Switzerland)
|
February 23, 2024
Diverse Role of <i>bla</i><sub>CTX-M</sub> and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales
Cody A Black, Raymond Benavides, Sarah M Bandy, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study
Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, et al.
Page
of 9
Search research articles
Search
Showing results (81-90 of 87) with videos related to
Sort By:
Page
of 9
You have reached the last page of results.
This site can display upto 87 results.
Plos One
|
March 21, 2015
Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients
Kelly R Reveles, Timothy R Juday, Matthew J Labreche, et al.
BMC Microbiology
|
January 15, 2021
Comparison of rectal swab, glove tip, and participant-collected stool techniques for gut microbiome sampling
Meghan I Short, Robert Hudson, Benjamin D Besasie, et al.
The Oncologist
|
June 19, 2023
Health Equity in Patients Receiving Durvalumab for Unresectable Stage III Non-Small Cell Lung Cancer in the US Veterans Health Administration
Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, et al.
Open Forum Infectious Diseases
|
January 30, 2020
Eosinopenia and Binary Toxin Increase Mortality in Hospitalized Patients With <i>Clostridioides difficile</i> Infection
Travis J Carlson, Bradley T Endres, Julie Le Pham, et al.
Drug and Alcohol Dependence
|
June 12, 2022
Availability of buprenorphine/naloxone films and naloxone nasal spray in community pharmacies in 11 U.S. states
Lucas G Hill, Lindsey J Loera, Sorina B Torrez, et al.
Antibiotics (Basel, Switzerland)
|
February 23, 2024
Diverse Role of <i>bla</i><sub>CTX-M</sub> and Porins in Mediating Ertapenem Resistance among Carbapenem-Resistant Enterobacterales
Cody A Black, Raymond Benavides, Sarah M Bandy, et al.
Current Oncology (Toronto, Ont.)
|
September 27, 2023
Durvalumab Treatment Patterns for Patients with Unresectable Stage III Non-Small Cell Lung Cancer in the Veterans Health Administration (VHA): A Nationwide, Real-World Study
Amanda M Moore, Zohra Nooruddin, Kelly R Reveles, et al.
Page
of 9